Treatment of Hodgkin's disease with intensive radiotherapy (>3000 rads) followed by combination chemotherapy has been associated with a 9 7% incidence of second malignancies including acute leukaemia, carcinoma of the colon, squamous cell carcinoma of the skin, and fibrosarcoma of the chest wall (Canellos et al., 1975) . We describe two cases of primary lung cancer occurring in a previous radiation port for Hodgkin's disease after remission had been obtained with intensive radiotherapy followed by combination chemotherapy. 
Discussion
The possibility of radiation and/or chemotherapy causing a second tumour can best be studied in patients surviving for prolonged periods after treatment for advanced malignant disease, such as Hodgkin's disease (Arseneau et al., 1972; Canellos et al., 1975; Schein and Winokur, 1975) . Canellos and co-workers (1975) identified second tumours in six of 62 patients (9-7%) treated with radiotherapy and chemotherapy for Hodgkin's disease. However, patients in complete remission after intensive radiotherapy followed by a relapse before receiving combination chemotherapy had the highest risk of developing second malignancies-18'5 times greater than expected when analysed according to age, sex, and man-years of follow-up (Canellos et al., 1975) . In both patients in this series complete remission was obtained after intensive radiotherapy, and relapse of Hodgkin's disease occurred before 'the administration of combination chemotherapy.
Prior to this report primary lung cancer occurring in the radiation port of patients with Hodgkin's disease treated with both radiotherapy and chemotherapy has not been emphasised. Possible causes of these second lung tumours include immunosuppressive action of chemotherapy, derangement of nucleic acid synthesis due to chemotherapy, radiation-induced cell transformation, impairment of cellular immunity in Hodgkin's disease, and a combination of the above factors (Gross et al., 1969; Arseneau et al., 1972; Penn, 1974; Canellos et al., 1975; Penn, 1976 
